TOKYO -- Japan plans to approve Merck's coronavirus pill for sale by the end of this month through an expedited process for priority drug candidates, the regulators said Friday.
The Japanese arm of the U.S. drugmaker, MSD, applied the same day to the health ministry to manufacture and market the oral medication, molnupiravir.
